Literature DB >> 32522065

Harmonizing light transmission aggregometry in the Netherlands by implementation of the SSC-ISTH guideline.

I C A Munnix1, R Van Oerle2, P Verhezen2, P Kuijper3, C M Hackeng4, H I J Hopman-Kerkhoff5, F Hudig6, D Van De Kerkhof7, A Leyte8, M P M De Maat9, R F M Oude Elferink10, J Ruinemans-Koerts11, M Schoorl12, J Slomp13, H Soons14, A Stroobants15, E Van Wijk16, Y M C Henskens2.   

Abstract

Light transmission aggregometry (LTA) is considered the gold standard method for evaluation of platelet function. However, there are a lot of variation in protocols (pre-analytical procedures and agonist concentrations) and results. The aim of our study was to establish a national LTA protocol, to investigate the effect of standardization and to define national reference values for LTA. The SSC guideline was used as base for a national procedure. Almost all recommendations of the SSC were followed e.g. no adjustment of PRP, citrate concentration of 109 mM, 21 needle gauge, fasting, resting time for whole blood and PRP, centrifugation time, speed and agonists concentrations. LTA of healthy volunteers was measured in a total of 16 hospitals with 5 hospitals before and after standardization. Results of more than 120 healthy volunteers (maximum aggregation %) were collected, with participating laboratories using 4 different analyzers with different reagents. Use of low agonist concentrations showed high variation before and after standardization, with the exception of collagen. For most high agonist concentrations (ADP, collagen, ristocetin, epinephrine and arachidonic acid) variability in healthy subjects decreased after standardization. We can conclude that a standardized Dutch protocol for LTA, based on the SSC guideline, does not result in smaller variability in healthy volunteers for all agonist concentrations.

Entities:  

Keywords:  Light transmission aggregometry; platelet aggregation; platelet disorders; platelet function; platelets; standardization

Mesh:

Year:  2020        PMID: 32522065     DOI: 10.1080/09537104.2020.1771549

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  2 in total

1.  Cryptogenic oozers and bruisers.

Authors:  Kristi J Smock; Karen A Moser
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

2.  Assessment of need for hemostatic evaluation in patients taking valproic acid: A retrospective cross-sectional study.

Authors:  Demi S Post; Arian van der Veer; Olaf E M G Schijns; Sylvia Klinkenberg; Kim Rijkers; G Louis Wagner; Vivianne H J M van Kranen-Mastenbroek; Paul C P H Willems; Paul W M Verhezen; Erik A M Beckers; Floor C J I Heubel-Moenen; Yvonne M C Henskens
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.